December 19, 2024

Large Acetaminophen Study Reveals New Risks

In a large cohort study of 180,483 acetaminophen users aged 65 or older, researchers found that use was associated with a 36% increased risk of lower gastrointestinal bleeding.

Conexiant

December 12, 2024

Phase 3 Data: Nemolizumab for Prurigo Nodularis Relief

A recent study published in JAMA Dermatology revealed the significant efficacy of nemolizumab in reducing pruritus and skin lesions in patients with moderate to severe prurigo nodularis.

Conexiant

December 10, 2024

ASCVD Risk Elevated in Cutaneous Lupus

Recent study in JAMA Dermatology shows patients with cutaneous lupus erythematosus have a 72% higher risk of developing atherosclerotic cardiovascular disease, emphasizing the need for targeted screening and management.

Conexiant

December 10, 2024

Biomarkers in Familial Mediterranean Fever: Therapy Insights

A recent study on familial Mediterranean fever revealed that nearly 56% of heterozygous patients who stopped colchicine therapy sustained remission with lower levels of specific biomarkers, highlighting the potential of personalized treatment for FMF patients.

Conexiant

December 03, 2024

Alcohol, Fruit Intake Linked to Lower Rheumatoid Arthritis Risk

A large meta-analysis of nearly 3 million participants found moderate alcohol consumption up to 60 g/week, along with higher intake of fruits and cereals, was associated with reduced rheumatoid arthritis risk, while tea and coffee consumption showed potential to increase risk.

Conexiant

November 27, 2024

Key Risk Factors for SARD-ILD Progression

A recent review identified significant risk factors for the progression of systemic autoimmune rheumatic disease-associated interstitial lung disease, emphasizing the importance of early identification and intervention for high-risk patients. The findings provide evidence-based insights for clinicians to guide risk assessment and optimize care.

Conexiant

November 26, 2024

Do Cancer Drugs Trigger Skin Issues?

A recent analysis reveals that nearly 50% of significant dermatologic adverse events linked to anticancer therapies are associated with targeted therapies, with rash, dry skin, and alopecia being the most commonly reported adverse events.

Conexiant

November 26, 2024

Constitutional Stiffness Links RA, CVD Risk

New study reveals the link between stiffness in joints, arteries, and skin with rheumatoid arthritis severity and cardiovascular disease risk.

Conexiant

November 26, 2024

Premature Ovarian Insufficiency Linked to Higher Autoimmune Disease Risk

A recent study showcases a significant link between premature ovarian insufficiency and severe autoimmune diseases, emphasizing the need for more research into the underlying immunological mechanisms.

Conexiant